One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Shiraz, Iran: The Largest Center for Pancreas Transplantation in the Middle East.
Nikeghbalian, Saman MD 1;Â Ali Malekhosseini, Seyed MD 1;Â Shamsaeefar, Alireza MD 1;Â Nikoupour, Hamed MD 1;Â Arasteh, Peyman MD, MPH 1;Â Dehghani, Masood MD 1
Research Highlights.
Beckett, Joseph BSc 1;Â Issa, Fadi DPhil, FRCS 1
What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2020-2021?-Report of the Basic and Translational Research Committee of the International Liver Transplantation Society.
Czigany, Zoltan MD, PhD 1;Â Bruggenwirth, Isabel MA MD 2;Â Ekser, Burcin MD, PhD 3;Â Abdelrahim, Maen MD, PhD, B Pharm 4;Â Bhat, Mamatha MD, PhD 5;Â Bonaccorsi-Riani, Eliano MD 6;Â Chen, Angela MD 7;Â Emmaullee, Juliet MD, PhD 8.9;Â Eymard, Corey MD 10;Â Ho, Cheng-Maw MD, PhD 11;Â Mas, Valeria R. PhD 10;Â Zarrinpar, Ali MD, PhD 12;Â Yuksel, Muhammed PhD 13;Â Martins, Paulo N. MD, PhD 14;Â Selzner, Markus MD 5
Innate-like B Cells: Local Drivers of Non-HLA Immunity in Rejecting Kidney Allografts?.
Karahan, Gonca E. PhD 1;Â Heidt, Sebastian PhD 1
The Moral Necessity to Increase Access to HCV+ Transplants With Early Treatment for HCV-naive Patients.
Richter, Benjamin I. MD 1;Â Parent, Brendan JD 2;Â Lonze, Bonnie E. MD, PhD 3
International Travel for Transplantation: Time for Transparency.
Lopez-Fraga, Marta PhD 1;Â Perez-Blanco, Alicia MD, PhD 2;Â Dominguez-Gil, Beatriz MD, PhD 2
The Fragility Index: The P-Value by Another Name?.
Li, Jennifer MBBS, FRACP 1,2;Â O'Connell, Philip J. MBBS, PhD 1,2
The Current Status of Endotherapy in the Management of Biliary Strictures After Right Lobe Living Donor Liver Transplantation.
Rela, Mohamed MS, FRCS, DSc 1;Â Rammohan, Ashwin MCh, FRCS, FACS 1
The Effect of Priority Given to Donor Card Holders on the Allocation of Livers for Transplant-Evidence From 7 Years of the Israeli Priority Program.
Martin, Dominique E. PhD 1
Obinutuzumab for Desensitization: An Unexpected Benefit?.
Jordan, Stanley C. MD 1
Surfing the Big Data Wave: Omics Data Challenges in Transplantation.
Ba, Rokhaya MSc 1,2; Geffard, Estelle PhD 1; Douillard, Venceslas MSc 1; Simon, Françoise MBA, PhD 1.3; Mesnard, Laurent MD, PhD 4.5; Vince, Nicholas PhD 1; Gourraud, Pierre-Antoine PhD, MPH 1; Limou, Sophie PhD 1,2
Current State of Evidence on Kidney Transplantation: How Fragile Are the Results?.
Budhiraja, Pooja MD 1;Â Kaplan, Bruce MD 2;Â Kalot, Mohammad MD 3;Â Alayli, Abdallah El MD 3;Â Dimassi, Ahmad MD 4;Â Chakkera, Harini A. MD, MPH 1;Â Heilman, Raymond MD 1;Â Edwards, Audrene S. MS 5;Â Mustafa, Reem A. MD, PhD, MPH 3
Macrophages in Transplantation: A Matter of Plasticity, Polarization, and Diversity.
Panzer, Sarah E. MD 1
Renal Normothermic Machine Perfusion: The Road Toward Clinical Implementation of a Promising Pretransplant Organ Assessment Tool.
Hamelink, Tim L. BSc 1;Â Ogurlu, Baran 1;Â De Beule, Julie MD 2;Â Lantinga, Veerle A. BSc 1;Â Pool, Merel BF MD, PhD 1;Â Venema, Leonie H. MSc 1;Â Leuvenink, Henri GD PhD 1;Â Jochmans, Ina MD, PhD 2.3;Â Moers, Cyril MD, PhD 1
Thrombomodulin-mediated Inhibition of Neutrophil Extracellular Trap Formation Alleviates Hepatic Ischemia-reperfusion Injury by Blocking TLR4 in Rats Subjected to Liver Transplantation.
Liu, Yanyao MD 1;Â Lei, Zilun MD 1;Â Chai, Hao MD 1;Â Xiang, Song MD 1;Â Wang, Yihua MD 1;Â Yan, Ping MD 1;Â Cao, Zhenrui MD 1;Â Pu, Xingyu MD 2;Â Wu, Zhongjun MD 1
Evaluation of Neutrophil Dynamics Change by Protective Effect of Tadalafil After Renal Ischemia/Reperfusion Using In Vivo Real-time Imaging.
Maruyama, Yuki MD 1;Â Araki, Motoo MD, PhD 1;Â Kidokoro, Kengo MD, PhD 2;Â Sogawa, Yuji MD, PhD 2;Â Yoshinaga, Kasumi MD 1;Â Mitsui, Yosuke MD, PhD 1;Â Sadahira, Takuya MD, PhD 1;Â Wada, Koichiro MD, PhD 1;Â Watanabe, Masami MD, PhD 1;Â Watanabe, Toyohiko MD, PhD 1;Â Kashihara, Naoki MD, PhD 2;Â Nasu, Yasutomo MD, PhD 1
Cardiac MicroRNA Expression Profile After Experimental Brain Death Is Associated With Myocardial Dysfunction and Can Be Modulated by Hypertonic Saline.
Ferreira, Ludmila Rodrigues Pinto PhD 1,2;Â Correia, Christian Jesus PhD 3;Â Zanoni, Fernando Luiz PhD 3;Â Carvalho-Silva, Ana Carolina MSc 1,2;Â Zaniratto, Ricardo BSc 4.5;Â da Silva Candido, Darlan MSc 4.5;Â Almeida, Rafael Ribeiro PhD 4.5;Â Breithaupt-Faloppa, Ana Cristina PhD 3;Â Cunha-Neto, Edecio MD, PhD 4,5,6;Â Moreira, Luiz Felipe P. MD, PhD 3
International Travel for Liver Transplantation: A Comprehensive Assessment of the Impact on the United States Transplant System.
Braun, Hillary J. MD 1;Â Amara, Dominic BA 2;Â Shui, Amy M. MA 1.3;Â Stock, Peter G. MD, PhD 1;Â Hirose, Ryutaro MD 1;Â Delmonico, Francis L. MD 4;Â Ascher, Nancy L. MD, PhD 1
The Effect of Priority Given to Donor Card Holders on the Allocation of Livers for Transplant-Evidence From 7 Years of the Israeli Priority Program.
Ashkenazi, Tamar PhD 1;Â Stoler, Avraham PhD 2;Â Mor, Eytan MD 3
Controlled DCD Liver Transplantation Is Not Associated With Increased Hyperfibrinolysis and Blood Loss After Graft Reperfusion.
Karangwa, Shanice A. MD 1.2;Â Adelmeijer, Jelle 1;Â Burgerhof, Johannes GM MSc 3;Â Lisman, Ton PhD 1;Â de Meijer, Vincent E. MD, PhD 2;Â de Kleine, Ruben H. MD 2;Â Reyntjens, Koen MEM MD 4;Â van den Berg, Aad P. MD, PhD 5;Â Porte, Robert J. MD, PhD 1,2;Â de Boer, Marieke T. MD, PhD 2
Usefulness of Controlled Attenuation Parameter and Liver Stiffness Measurement for the Identification of Extended-criteria Donors and Risk-assessment in Liver Transplantation.
Duarte-Rojo, Andres MD, PhD 1,2;Â Heimbach, Julie K. MD 3;Â Borja-Cacho, Daniel MD 2.4;Â Barone, Gary W. MD 2;Â Shaheen, Mohammed F. MD 3.5;Â Lamps, Laura W. MD 6;Â Graham, Rondell P. MD 7;Â Tan, Ek Khoon MBBS, MPH 3;Â Concepcion, Waldo MD 8;Â Kim, W. Ray MD, MBA 9
The Classification of Biliary Strictures in Patients With Right-Lobe Liver Transplant Recipients and Its Relation to Traversing the Stricture With a Guidewire.
Parlak, Erkan MD 1;Â Simsek, Cem MD 1;Â Koksal, Aydin Seref MD 2;Â Eminler, Ahmet Tarik MD 2;Â Unal, Emre MD 3;Â Ciftci, Turkmen Turan MD 3;Â Akinci, Devrim MD 3;Â Yilmaz, Sezai MD 4
Sex Difference in the Tolerance of Hepatic Ischemia-reperfusion Injury and Hepatic Estrogen Receptor Expression According to Age and Macrosteatosis in Healthy Living Liver Donors.
Han, Sangbin MD, PhD 1;Â Cho, Junhun MD 2;Â Wi, Wongook MD 1;Â Won Lee, Kyo MD, PhD 3;Â Hwa Cha, Hyun MD, PhD 4;Â Lee, Sanghoon MD, PhD 3;Â Hyun Ahn, Joong MS 5;Â Kim, Seonwoo PhD 5;Â Sung Choi, Gyu MD, PhD 3;Â Man Kim, Jong MD, PhD 3;Â Ha, Sang Yun MD, PhD 2;Â Soo Kim, Gaab MD, PhD 1;Â Joh, Jae-Won MD, PhD 3
A Programmatic Response, Including Bamlanivimab or Casirivimab-imdevimab Administration, Reduces Hospitalization and Death in COVID-19 Positive Abdominal Transplant Recipients.
Ahearn, Aaron J. MD, PhD 1;Â Thin Maw, Thin MD 2;Â Mehta, Rishi MD 2;Â Emmaullee, Juliet MD, PhD 1;Â Kim, Jim MD 1;Â Blodget, Emily MD 2;Â Kahn, Jeffrey MD 2;Â Sher, Linda MD 1;Â Genyk, Yuri MD 1
Characteristics and Donation Outcomes of Potential Organ Donors Perceived to Be at Increased Risk for Blood-borne Virus Transmission: An Australian Cohort Study 2010-2018.
Waller, Karen MJ MBBS 1;Â De La Mata, Nicole L. PhD 1;Â Rosales, Brenda M. MPH 1;Â Hedley, James A. MBioStat 1;Â Kelly, Patrick J. PhD 1;Â Thomson, Imogen K. MD 1;Â O'Leary, Michael J MD 2.3;Â Cavazzoni, Elena PhD 2;Â Ramachandran, Vidiya PhD 4;Â Rawlinson, William D. Ph.D. 4.5;Â Wyburn, Kate R. PhD 6.7;Â Webster, Angela C. PhD 1.8
Risk Prediction for Delayed Allograft Function: Analysis of the Deterioration of Kidney Allograft Function (DeKAF) Study Data.
Matas, Arthur J. MD 1;Â Helgeson, Erika PhD 2;Â Fieberg, Ann PhD 2;Â Leduc, Robert PhD 2;Â Gaston, Robert S. MD 3;Â Kasiske, Bertram L. MD 4;Â Rush, David MD 5;Â Hunsicker, Lawrence MD 6;Â Cosio, Fernando MD 7;Â Grande, Joseph P. MD, PhD 8;Â Cecka, J. Michael PhD 9;Â Connett, John PhD 2;Â Mannon, Roslyn B. MD 10
Obinutuzumab in Kidney Transplantation: Effect on B-cell Counts and Crossmatch Tests.
NasrAllah, Mohamed M. MSc, MD 1,2;Â Elalfy, Mahmoud MSc 2,3;Â El Ansary, Mervat MSc, MD 4;Â Elmeseery, Yasser MSc 1,2;Â Amer, Ihab MSc 2.5;Â Malvezzi, Paolo MD 6;Â Rostaing, Lionel MD, PhD 6.7
Angiotensin II Type 1 Receptor Antibody-mediated Rejection Following Orthotopic Heart Transplant: A Single-center Experience.
Moreno, Jonathan D. MD, PhD 1;Â Verma, Amanda K. MD 1;Â Kopecky, Benjamin J. MD, PhD 1;Â Dehner, Carina MD, PhD 2;Â Kostelecky, Nicolas MD 2;Â Vader, Justin M. MD, MPHS 1;Â Lin, Chieh-Yu MD, PhD 2;Â Schilling, Joel D. MD, PhD 1,2
Long-term Efficacy and Safety of Everolimus Versus Mycophenolate in Kidney Transplant Recipients Receiving Tacrolimus.
Nunes Ficher, Klaus MD 1;Â Dreige, Yasmin PharmD 1;Â Gessolo Lins, Paulo Ricardo MD 1;Â Nicolau Ferreira, Alexandra MD, PhD 1;Â Toniato de Rezende Freschi, Juliana MD 1;Â Linhares, Kamilla MD 1;Â Stopa Martins, Solen MD, MSc 1;Â Custodian, Luciana MD 1;Â Cristelli, Marina MD, PhD 1;Â Viana, Laila MD, MSc 1;Â Wagner Santos, Daniel MD, MSc 2;Â de Marco, Renato MSc 3;Â Gerbase-DeLima, Maria MD, PhD 3;Â Proenca, Henrique MD 4;Â Aguiar, Wilson MD, PhD 5;Â Nakamura, Monica PharmD 1;Â Rosso Felipe, Claudia PharmD, PhD 1;Â Medina Pestana, Jose MD, PhD 1;Â Tedesco Silva, Helio Jr MD, PhD 1
Estimated GFR Slope in Kidney Transplant Patients: When the Error Is Random.
Luis Lima, Sergio PhD 1;Â Marrero Miranda, Sunday MD 2;Â Gonzalez Rinne, Ana MD 2;Â Negrin Mena, Natalia 3;Â Perez Tamajon, Lourdes MD 2;Â Rodriguez, Aurelio PhD 2;Â Alvarez Gonzalez, Alejandra MD 2;Â Gonzalez Delgado, Alejandra 4;Â Ferrer Moure, Carmen 4;Â Gonzalez Rinne, Federico 3;Â Martin, Laura Diaz 3;Â Rodriguez Rodriguez, Ana Elena PhD 3;Â Gomez Diaz, Laura MD 5;Â Garcia Cabrera, Veronica MD 5;Â Jimenez Sosa, Alejandro PhD 6;Â Torres, Armando PhD 2;Â Ortiz, Alberto PhD 1.7;Â Gaspari, Flavio PhD 3;Â Porrini, Esteban PhD, MD 3.8
Preemptive Kidney Transplantation Is Associated With Transplantation Outcomes in Children: Results From the French Kidney Replacement Therapy Registry.
Prezelin-Reydit, Mathilde MD 1;Â Madden, Iona MD 2;Â Macher, Marie-Alice MD 3.4;Â Salomon, Remi MD, PhD 5;Â Sellier-Leclerc, Anne-Laure MD 6;Â Roussey, Gwenaelle MD 7;Â Lahoche, Annie MD 8;Â Garaix, Florentine MD 9;Â Decramer, Stephane MD, PhD 10;Â Ulinski, Tim MD, PhD 11;Â Row, Marc MD 12;Â Dunand, Oliver MD 13;Â Merieau, Elodie MD 14;Â Pongas, Marios MD 15;Â Zaloszyc, Ariane MD, PhD 16;Â Baudouin, Veronique MD 3;Â Berard, Etienne MD 17;Â Couchoud, Cecile MD, PhD 4;Â Leffondre, Karen Ph.D. 1.18;Â Harambat, Jerome MD, PhD 1,2,18
Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults.
Wang, Yun Zu Michele MD 1.2;Â Teusink-Cross, Ashley PharmD 1.3;Â Elborai, Yasser MD, PhD 4.5;Â Krupski, M. Christa DO, MPH 1.2;Â Nelson, Adam S. MBBS 1,2;Â Grimley, Michael S. MD 1,2;Â Flannery, Amanda APRN-CNP 1;Â Mehta, Parinda A. MD 1.2;Â Bleesing, Jacob J. MD, PhD 1,2;Â Chandra, Sharat MD, MRCPCH 1.2;Â Kumar, Ashish R. MD, PhD 1,2;Â Myers, Kasiani C. MD 1.2;Â Davies, Stella M. MBBS, PhD 1,2;Â Khandelwal, Pooja MD 1,2
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?.
Cotugno, Nicola MD, PhD 1,2;Â Pighi, Chiara PhD 1;Â Morrocchi, Elena PhD 1;Â Ruggiero, Alessandra PhD 1;Â Amodio, Donato MD, PhD 1;Â Medri, Chiara MS 1;Â Colagrossi, Luna PhD 3;Â Russo, Cristina PhD 3;Â Di Cesare, Silvia PhD 1;Â Santilli, Veronica MD 1;Â Manno, Emma Concetta MD 1;Â Zangari, Paola MD 1;Â Giancotta, Carmela MD 1;Â Bernardi, Stefania MD 4;Â Nicolosi, Luciana MD 5;Â Ciofi Degli Atti, Marta MD 6;Â Raponi, Massimiliano MD 6;Â Zaffina, Salvatore MD 7;Â Alfieri, Sara MD 8;Â Kirk, Richard MD, PhD 8;Â Bolt, Carlo Federico MD, PhD 3;Â Rossi, Paolo MD, PhD 1,2;Â Amodeo, Antonio MD 8;Â Palma, Paolo MD, PhD 1,2
Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case Series.
Chang, Amy MD 1; Alejo, Jennifer L. MD 1; Abedon, Aura T. BS 1; Mitchell, Jonathan MBBS 1,2; Chiang, Teresa P.-Y. MD, MPH 1; Boyarsky, Brian J. MD, PhD 1; Avery, Robin K. MD 3; Tobian, Aaron AR MD, PhD 3; Levan, Macey L. JD, PhD 1.4; Warren, Daniel S. PhD 1; Massie, Allan B. PhD, MHS 1; Garonzik-Wang, Jacqueline M. MD, PhD 5; Segev, Dorry L. MD, PhD 1.6; Werbel, William A. MD 3
Vaccination for HAV: A Lesson From Acute Hepatitis A Superinfection on Chronic B Hepatitis With Lifesaving Living Donor Liver Transplantation for Hepatic Failure.
Lin, Shu-Hsien MD 1;Â Lin, Ming-Tsung MD 1;Â Wang, Chih-Chi MD 2,3,4;Â Chen, Chao-Long MD 2,3,4;Â Hu, Tsung-Hui MD 1,2,3;Â Chiu, King-Wah MD 1,2,3
Geographic Variation in the Utilization of HCV-viremic Donors into HCV-negative Recipients.
Bekki, Yuki MD, PhD 1;Â Myers, Bryan MD 2
The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients.
Cotter, Thomas G. MD, MS 1;Â Charlton, Michael M.D. 2
The Delay of Arterialization After Initial Portal Reperfusion More Than Warm Ischemia Time May Determine Ischemic-type Biliary Injury.
Ly, Mark MS 1.2;Â Lau, Ngee-Soon MD, FRACS 1,2;Â McKenzie, Catriona MBBS, FRCPA 2.3;Â Kench, James G. MBBS, FRCPA 2.3;Â McCaughan, Geoffrey MBBS, PhD, FRACP 1,2,4;Â Crawford, Michael MBBS, MMed, FRACS 1;Â Pulitano, Carlo MD, PhD, FRACS 1,2
Apophysomyces Variabilis Infection in Transplant Recipients due to Unrecognized Infection in an Intravenous Drug-Using Donor.
Boan, Peter FRACP, FRCPA 1,2;Â Pang, Stanley Ph.D. 2.3;Â Mowlaboccus, Shakeel PhD 2.3;Â Wrobel, Jeremy P. FRACP, PhD 4.5;Â Musk, Michael FRACP 4;Â Lavender, Melanie FRACP 4;Â Yaw, Meow Cheong FRACP 4;Â Hernest, Adrian FRACP 4;Â MacQuillan, Gerry FRACP, FRCP, PhD 6.7;Â Dembo, Lawrence G. FRACP 8;Â Coombs, Geoffrey W. Ph.D. 2.3;Â Gardam, Dianne J. BSc 2;Â Pereira, Lynette A. FRACP, FRCPA 1,2;Â Robinson, J. Owen FRACP 1,2,3,9
Authors' Response to Odugoudar et al: Poor Kidney Transplant Outcomes and Higher Organ Discard Rate Secondary to Macroscopic Arteriosclerosis of Renal Artery: More Evidence Needed to Prove Correlation.
Keijbeck, Anke MD 1;Â Veenstra, Rob 2;Â Pol, Robert A. MD, PhD 2;Â Konijn, Cynthia 3;Â Jansen, Nichon PhD 3;Â van Goor, Harry PhD 4;Â Hoitsma, Andries J. MD, PhD 3;Â Peutz-Kootstra, Carine J. MD, PhD 1;Â Moers, Cyril MD, PhD 2
The Impact of Donor Hepatectomy Time on Liver Transplantation Outcomes.
Bekki, Yuki MD, PhD 1;Â Fenig, Yaniv MD 1
Reply to: "The Impact of Donor Hepatectomy Time on Liver Transplantation Outcomes."
Gilbo, Nicholas MD, PhD 1,2;Â Fieuws, Steffen PhD 3;Â Jochmans, Ina MD, PhD 1,2;Â Monbaliu, Diethard MD, PhD 1,2
Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series: Erratum.
